miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients

Ovarian cancer (OC) remains a leading cause of gynecological cancer‐related death worldwide, characterized by poor 5‐year survival. Molecular markers could serve as crucial tools of personalized prognosis and therapy. Herein, we present miR‐181a as novel predictor of OC prognosis, using five indepen...

Full description

Saved in:

Bibliographic Details
Published in:	International Journal of Cancer Vol. 147; no. 12; pp. 3560 - 3573
Main Authors:	Panoutsopoulou, Konstantina, Avgeris, Margaritis, Magkou, Paraskevi, Mavridis, Konstantinos, Dreyer, Tobias, Dorn, Julia, Obermayr, Eva, Reinthaller, Alexander, Michaelidou, Kleita, Mahner, Sven, Vergote, Ignace, Loverix, Liselore, Braicu, Ioana, Sehouli, Jalid, Zeillinger, Robert, Magdolen, Viktor, Scorilas, Andreas
Format:	Journal Article
Language:	English
Published:	Hoboken, USA Wiley 15.12.2020 John Wiley & Sons, Inc Wiley Subscription Services, Inc
Subjects:	Adult Aged Aged, 80 and over Biomarkers, Tumor Biomarkers, Tumor - genetics Cancer Cancer therapies Chemotherapy Cohort Studies Cystadenocarcinoma, Serous Cystadenocarcinoma, Serous - genetics Cystadenocarcinoma, Serous - therapy Cytoreduction Surgical Procedures Disease Progression epithelial ovarian cancer Female Gene Expression Profiling Gene Expression Regulation, Neoplastic Gynecological cancer Health Sciences Humans Medical prognosis Medical research MicroRNAs MicroRNAs - genetics microRNA‐181a Middle Aged molecular diagnostics noncoding RNA Ovarian cancer Ovarian Neoplasms Ovarian Neoplasms - genetics Ovarian Neoplasms - therapy ovarian tumors Patients Platinum Platinum - therapeutic use Precision medicine Prognosis Surgery Survival Survival Analysis Treatment Outcome Up-Regulation Επιστήμες Υγείας molecular diagnostics microRNA-181a noncoding RNA epithelial ovarian cancer ovarian tumors
ISSN:	0020-7136, 1097-0215, 1097-0215
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!